BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 6085662)

  • 1. Treatment results of stage III germinal testicular tumors.
    Akdaş A; Kirkali Z; Altuğ U; Ilker Y
    Turk J Pediatr; 1984; 26(1-4):301-6. PubMed ID: 6085662
    [No Abstract]   [Full Text] [Related]  

  • 2. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with PVB in non seminomatous germ-cell cancer of the testis.
    Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
    Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 5. Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumors.
    Bodrogi I; Baki M; Horti J; Liszka G; Ottó S; Hindy I; Sugár J; Eckhardt S
    Neoplasma; 1990; 37(4):445-50. PubMed ID: 1700311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VP-16-213 (etoposide) in the management of germinal testis tumors.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():391-400. PubMed ID: 2421333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 8. The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
    Stoter G
    Prog Clin Biol Res; 1985; 203():437-47. PubMed ID: 2421335
    [No Abstract]   [Full Text] [Related]  

  • 9. Our experience in regard to the relationship between the size of retroperitoneal lymph node metastases and the effect of chemotherapy in non seminomatous germ cell tumors.
    Guazzieri S; Ferro G; Lembo A; Merlo F; Sperandio P; Pagano F
    Prog Clin Biol Res; 1985; 203():457-62. PubMed ID: 2421337
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of the testis: a new paradigm.
    Einhorn LH
    Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
    [No Abstract]   [Full Text] [Related]  

  • 12. [Raynaud's disease after treatment with bleomycin and vinblastine].
    Dzieza-Lalowicz I; Mykała-Cieśla J
    Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
    Srougi M; Simon SD; de Góes GM
    AMB Rev Assoc Med Bras; 1985; 31(3-4):52-8. PubMed ID: 2417287
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cisplatin-induced nephrotoxic side effects of cytostatic chemotherapy of testicular tumors].
    Rebmann U; Oehlmann U; Warnack W
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(2):83-5. PubMed ID: 1703720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of stage I nonseminomatous testicular cancer with one cycle of adjuvant chemotherapy].
    Corti Ortíz D; Fonerón Burgos A; Troncoso Schifferli L
    Actas Urol Esp; 1997; 21(10):961-3. PubMed ID: 9494159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
    Dunlop PR; Hendy-Ibbs PM
    Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
    Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
    Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.